Entacapone

恩他卡朋

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEntacapone
Drug Alias Name恩托卡朋entacaponeentacaponaentacaponumComtess +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatechol-O-methyl transferase inhibitors
TargetsCatechol-O-methyl transferase
Therapy Area/IndicationsObesityTachycardiaParkinson Disease +[4] 
Global Approved IndicationsParkinson Disease
Approved Indications in ChinaParkinson Disease
Original Approved Country/TerritoryEU
Original Approved Date1998/09/16
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesNational Center For Advancing Translational SciencesNovartis Pharma AgOrion Pharma A/S +[4] 
Inactive CompaniesNational Institute Of Biological Sciences, Beijing
Active IndicationsTachycardiaParkinson DiseaseOrthostatic Intolerance
Inactive IndicationsObesity

Other Information

ATC CodeN04BX02
Related LinksWikipediaDrugBankKEGG